This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
April 25, 2022
Priothera to present an abstract at the TANDEM Meetings / Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR – April 23-26 2022
April 21, 2022
Vicore launches COMPANION, a clinical study investigating the benefit of digital therapy on anxiety in patients with idiopathic pulmonary fibrosis (IPF)
April 21, 2022
Oncopeptides publishes the 2021 Annual Report
April 21, 2022
Targovax ASA announces the appointment of two new Board Directors
April 19, 2022
Pulmonx to Report First Quarter 2022 Financial Results on May 3, 2022
April 13, 2022
BONESUPPORT Holding AB publishes Annual Report 2021
April 11, 2022
Priothera Receives First Regulatory Approvals to Start a Global Pivotal Study with Mocravimod in Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
April 11, 2022
Spruce Biosciences Appoints Libbie Mansell, Ph.D., M.B.A., R.A.C., as Chief Regulatory and Quality Officer
April 08, 2022
Carisma Therapeutics to Present Engineered Cell Therapy Data at The American Association for Cancer Research Annual Meeting
April 07, 2022
Vicore Pharma publishes the Annual Report for 2021